Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
暂无分享,去创建一个
E. Mazzon | P. Bramanti | S. Mammana | P. Fagone | M. Petralia | F. Nicoletti | K. Mangano | R. Di Marco | M. Basile | Flaminia Spinasanta